Summary & Overview
CPT 32562: Intrapleural Fibrinolytic Administration, Subsequent Days
CPT code 32562 denotes the daily, post-initial administration of an intrapleural fibrinolytic agent delivered via a chest tube or catheter to dissolve fibrinous material in the pleural space. The code captures ongoing therapeutic management of complex pleural collections such as loculated pleural effusions or empyema where fibrinous septations impair drainage. Nationally, this procedure influences hospital length of stay, resource utilization for chest tube management, and clinical pathways for pleural infection and complicated effusions.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of what CPT code 32562 represents, the typical clinical and care settings where it is used, and the payment and coding context relevant to hospital-based and procedural care. The publication outlines benchmarks and policy considerations affecting coverage and reimbursement, clarifies clinical context for use of intrapleural fibrinolytics, and highlights practical coding guidance such as service-day reporting (this code applies on each treatment day after the first). Data elements not provided in the input are noted as unavailable. The material is intended for clinicians, coding professionals, and policy analysts seeking a national perspective on coding and operational implications for intrapleural fibrinolytic therapy.
Billing Code Overview
CPT code 32562 describes the injection of a chest tube or catheter with an agent to dissolve fibrin proteins in the patient’s chest. This code applies to services performed on each day of treatment after the first and captures the ongoing therapeutic administration intended to lyse fibrinous septations within the pleural space.
-
Service type: Therapeutic intrapleural fibrinolytic administration
-
Typical site of service: Hospital inpatient or outpatient settings where chest tubes or pleural catheters are managed (for example, inpatient wards, observation units, or procedural areas supporting chest tube care)
Clinical & Coding Specifications
Clinical Context
A typical patient is a hospitalized adult with a pleural infection or complicated parapneumonic effusion who previously had an indwelling chest tube placed for drainage. After initial chest tube placement and drainage, persistent loculated pleural fluid with fibrinous septations is identified on chest radiograph or ultrasound and the patient continues to have inadequate drainage, ongoing fever, leukocytosis, or respiratory compromise. The provider performs intrapleural fibrinolytic instillation via the existing chest tube on the first day (initial instillation) and then repeats daily dosing as clinically indicated. 32562 specifically represents subsequent-day therapeutic instillations of a fibrinolytic agent (for example, tissue plasminogen activator) through the chest tube to lyse fibrin and improve drainage. Typical workflow: review imaging and clinical parameters, verify existing chest tube patency, prepare fibrinolytic per facility protocol, instill agent through the chest tube, clamp for the prescribed dwell time per protocol, then reopen to drainage; document dose, dwell time, patient response, and any complications. Typical site of service is an inpatient hospital unit, step-down unit, or intensive care unit; the procedure is performed at bedside under standard precautions, often with nursing and respiratory support available.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services |